Media Releases

Dear Valued Customers,

As a global biotech company committed to advancing life sciences by innovative enzyme technology, we have always prioritized empowering our clients in their pursuit of scientific breakthroughs and improvements in human health. Your trust and support over the years have been invaluable as we work together to drive progress in science and health, and we are deeply grateful for that.

To meet the varying needs of our customers, we leverage our expertise and expand the application fields in life science, bio-medicine, and in vitro diagnostics, offering one-stop solutions with our reagents, instruments, and consumables. Our global presence, with wholly-owned subsidiaries and warehouses in major markets and AEO Advanced Certification ensuring a stable and rapid multi-center supply chain, allows us to serve over 30,000 customers across more than 60 countries and regions. To enhance our local capabilities, we have built diverse and multilingual teams further engage and connect with local customers effectively. Thanks to their trust and our dedicated team’s efforts, we achieved steady growth in 2024, with our annual revenue reaching nearly $200 million.

Despite the challenging international environment, our mission remains unwavering. We are fully aware of the potential impacts of evolving trade dynamics, including tariffs policies. In response, we are actively enhancing our supply chain advantages, optimizing internal cost controls, and improving efficiency to minimize the impact on our customers. Our goal remains to provide affordable, critical technology support for global research, ensuring efficient and high-quality products and services. 

Meanwhile, we are closely monitoring policy developments and have established a dynamic risk assessment mechanism to navigate these uncertain times. Our commitment to internationalization is unwavering, as we adapt with a positive attitude and flexible strategies. As a multinational scientific supplier, we focus on addressing the business continuity challenges faced by all our customers. We will continue to accelerate our global manufacturing deployment to better navigate future uncertainties. In key markets, including the United States, Canada, the United Kingdom, Hungary, Germany, Australia, Indonesia, and Singapore, we have established registered local entities and teams of local employees to better serve our customers. Throughout this journey, we strive to make a positive impact on the societies we operate in by integrating locally, creating job opportunities, paying taxes, and fostering sustainable development. We believe in building lasting and meaningful relationships wherever we are. 

We apologize for any inconvenience these circumstances may cause. Should you have any questions or require further clarification about your running agreement(s), please do not hesitate to reach out to your Vazyme sales representatives. We are always ready to assist you.

Guided by our vision, "For Science For Health," we believe science knows no borders, and collaboration leads to future success. Helping our customers unlock new frontiers in scientific exploration and develop innovative solutions is the driving force behind our efforts at Vazyme. Together, we push the boundaries of science to overcome major health challenges and build a healthier future for all.

Thank you for your continued trust and partnership.

Sincerely,

Dr. Leo Zhang  

Head of International Business Division & Vice President of Vazyme